HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Iklé Selected Research

Therapeutics

9/2013Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Iklé Research Topics

Disease

3Vasculitis (Vasculitides)
06/2015 - 09/2013
2Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
06/2015 - 09/2013
2Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
06/2015 - 09/2013
1Disease Progression
06/2015

Drug/Important Bio-Agent (IBA)

3Rituximab (Mabthera)FDA Link
06/2015 - 09/2013
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
06/2015 - 09/2013
2Prednisone (Sone)FDA LinkGeneric
06/2015 - 09/2013
1Peptide Hydrolases (Proteases)FDA Link
06/2015
1GlucocorticoidsIBA
06/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2013
1Azathioprine (Imuran)FDA LinkGeneric
09/2013

Therapy/Procedure

1Therapeutics
09/2013
1Remission Induction
09/2013